Vogelmeier CF, Rabe KF, Bhatt SP, Hanania NA, et al. Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores. Respir Med 2025;241:108015.
PMID: 40024335